Lacrimal Sac/Nasolacrimal Duct Tumors Masquerading as PANDO: Selective-Biopsy Yield, Imaging Red Flags, and Oncologic Outcomes: A Systematic Review

Bratosin, Felix

Open source

DOI
10.17605/osf.io/ew3mv
Published
2025
Container
Not recorded
Publisher
OSF Registries
Open access
no

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.17605/osf.io/ew3mv,
  title = {Lacrimal Sac/Nasolacrimal Duct Tumors Masquerading as PANDO: Selective-Biopsy Yield, Imaging Red Flags, and Oncologic Outcomes: A Systematic Review},
  author = {Bratosin, Felix},
  year = {2025},
  doi = {10.17605/osf.io/ew3mv},
  url = {https://doi.org/10.17605/osf.io/ew3mv}
}

RIS

TY  - JOUR
TI  - Lacrimal Sac/Nasolacrimal Duct Tumors Masquerading as PANDO: Selective-Biopsy Yield, Imaging Red Flags, and Oncologic Outcomes: A Systematic Review
AU  - Bratosin, Felix
PY  - 2025
DO  - 10.17605/osf.io/ew3mv
UR  - https://doi.org/10.17605/osf.io/ew3mv
ER  - 

APA

Felix, B. (2025). Lacrimal Sac/Nasolacrimal Duct Tumors Masquerading as PANDO: Selective-Biopsy Yield, Imaging Red Flags, and Oncologic Outcomes: A Systematic Review. https://doi.org/10.17605/osf.io/ew3mv

Source records